We are live on ! Find out more
BIOTU

Biotech Acquisition Company Unit
BIOTU

Delisted

BIOTU was delisted on the 2nd of February, 2023.

Back to rankings

59 hedge funds and large institutions have $118M invested in Biotech Acquisition Company Unit in 2021 Q1 according to their latest regulatory filings, with 59 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
59
Holders Change
+59
Holders Change %
–
% of All Funds
1.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
59
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AC
Aristeia Capital
Connecticut
+$11.8M
2
HIM
HGC Investment Management
Ontario, Canada
+$11.3M
3
GCL
Glazer Capital LLC
New York
+$10.8M
4
BCM
BlueCrest Capital Management
Jersey
+$10.3M
5
LA
Linden Advisors
New York
+$6.98M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
LP
26
LMR Partners
United Kingdom
$989K +$1.03M +100,000 New
SCM
27
Shaolin Capital Management
Florida
$989K +$1.03M +100,000 New
SSA
28
Schonfeld Strategic Advisors
New York
$935K +$972K +94,500 New
FTCM
29
First Trust Capital Management
Illinois
$890K +$926K +90,000 New
HF
30
HRT Financial
New York
$887K +$923K +89,754 New
RA
31
Ramius Advisors
New York
$870K +$905K +87,960 New
Walleye Trading
32
Walleye Trading
New York
$791K +$823K +80,000 New
WC
33
Wealthspring Capital
New York
$614K +$638K +62,050 New
Susquehanna International Group
34
Susquehanna International Group
Pennsylvania
$598K +$622K +60,459 New
Alyeska Investment Group
35
Alyeska Investment Group
Illinois
$593K +$617K +60,000 New
YCM
36
Yakira Capital Management
Connecticut
$532K +$554K +53,818 New
AA
37
AQR Arbitrage
Connecticut
$524K +$545K +53,000 New
CC
38
Centiva Capital
New York
$495K +$514K +50,000 New
LC
39
Littlejohn & Co
Connecticut
$495K +$514K +50,000 New
WCMNY
40
Westchester Capital Management (New York)
New York
$494K +$514K +50,000 New
BI
41
Bulldog Investors
New Jersey
$445K +$463K +45,000 New
SMA
42
Sage Mountain Advisors
Georgia
$276K +$287K +27,950 New
BCM
43
BCK Capital Management
Connecticut
$264K +$275K +26,730 New
Royal Bank of Canada
44
Royal Bank of Canada
Ontario, Canada
$252K +$262K +25,478 New
GCIA
45
Gabelli & Co Investment Advisers
New York
$251K +$261K +25,400 New
Janus Henderson Group
46
Janus Henderson Group
United Kingdom
$248K +$257K +25,000 New
COPPSERS
47
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$247K +$257K +25,000 New
DIG
48
DeepCurrents Investment Group
New York
$247K +$257K +25,000 New
OAC
49
OMERS Administration Corp
Ontario, Canada
$247K +$257K +25,000 New
RCM
50
Rivernorth Capital Management
Florida
$247K +$257K +25,000 New
1
2
3

BIOTU Hedge Fund Activity: Q1 2021 in Review

59 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Biotech Acquisition Company Unit (BIOTU) for Q1 2021, worth a combined $118M.

Buyers outnumbered sellers: 59 funds opened new BIOTU positions and 0 closed out — a net gain of 59 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Aristeia Capital, opening a new position worth an estimated $11.8M.

  • 59 institutional investors held Biotech Acquisition Company Unit (BIOTU) as of Q1 2021, up from 0 in Q4 2020.
  • Funds reported $118M of Biotech Acquisition Company Unit stock for Q1 2021.
  • 59 funds opened new Biotech Acquisition Company Unit positions in Q1 2021 and 0 closed out, a net change of +59 holders.
  • The largest Biotech Acquisition Company Unit buyer in Q1 2021 was Aristeia Capital, an estimated $11.8M added.

Based on aggregated 13F filings for Q1 2021.